FDA advisors recommend J&J boosters for all as agency eyes mix-and-match doses

Enlarge / Boxes of Johnson & Johnson’s Janssen COVID-19 vaccine at a vaccination site in Florida.Getty | Paul Hennessy

A committee of independent advisors for the Food and Drug Administration on Friday voted unanimously in favor of authorizing a second dose of the Johnson & Johnson COVID-19 vaccine to everyone 18 years of age and older, two or more months after a person has received the first dose.

It is the third time the FDA’s advisory committee has recommended additional COVID-19 doses in recent weeks to bolster protection. But the reviewed data, discussion, and vote today were significantly different from the booster-authorization

→ Continue reading at Ars Technica

Related articles


Share article

Latest articles